Catheter Market Overview:
The catheters market is projected to grow at a CAGR of approximately 7–8% through 2028. This growth is primarily driven by the rising incidence of chronic conditions such as urinary disorders and kidney failure, growing demand for minimally invasive surgical procedures, increasing cases of incontinence due to the expanding global geriatric population, and ongoing technological advancements in catheter design and functionality.
Download Sample Copy: https://meditechinsights.com/catheter-market/request-sample/
A catheter is a medical device used for therapeutic purposes, disease management, or during surgical procedures. It is inserted into the body to enable the drainage of bodily fluids or the delivery of medications.
Rising Prevalence of Urinary Incontinence Fuels Adoption of Urological Catheters
Urinary incontinence represents a significant global health and social challenge, affecting more than 400 million people worldwide, with numbers continuing to rise. Globally, approximately one in three women over the age of 35 and one in four men over the age of 40 experience some form of incontinence.
The increasing burden of urinary incontinence is expected to drive growth in the global catheter market over the coming years. According to the Association for Women’s Health Care, women are twice as likely as men to develop urinary incontinence. Around one-third of women over 35 experience stress incontinence, a figure that rises to nearly half of women over the age of 65. Additionally, an estimated one million men in the U.S. are affected by stress urinary incontinence, while nearly 18 million U.S. women experience involuntary urine leakage. These figures underscore the high prevalence of stress urinary incontinence and highlight its role as a key factor accelerating the global adoption of urological catheters.
Technological Advancements Driving Market Growth
Technological innovation, coupled with the growing demand for minimally invasive procedures, is expected to significantly boost catheter sales worldwide. Advancements such as antimicrobial coatings and the development of smaller, more flexible catheters are helping reduce complications such as restenosis, the re-narrowing of blood vessels over time. The increasing incidence of peripheral vascular diseases, often associated with chronic conditions like diabetes, has further supported the adoption of catheter-based interventions.
Download Sample Copy: https://meditechinsights.com/catheter-market/request-sample/
Minimally invasive procedures, including angioplasty, have become standard practices in general surgery due to improved patient outcomes, shorter recovery times, and the availability of advanced catheter technologies. The rising preference for angioplasty over conventional surgical approaches has contributed to increased catheter utilization, thereby supporting overall market growth.
Recognizing the market’s potential, leading companies continue to introduce technologically advanced catheter solutions. For example, in May 2023, Abbott received FDA clearance for its TactiFlex ablation catheter, designed to treat abnormal heart rhythms. The catheter features a flexible electrode tip and contact force-sensing technology aimed at improving outcomes for patients with atrial fibrillation.
Competitive Landscape of the Catheters Market
The global catheters market is highly competitive, with major players including Medtronic, Teleflex Incorporated, Abbott, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Coloplast, Johnson & Johnson Services, Terumo Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, ConvaTec Group, Hollister Incorporated, Stryker, Cook Medical, and Merit Medical Systems, among others.
Browse Report: https://meditechinsights.com/catheter-market/
Strategic Initiatives Strengthening Market Presence
Market participants are employing a combination of organic and inorganic growth strategies to strengthen their competitive positioning. These strategies include regulatory approvals, new product launches, strategic investments, and mergers and acquisitions aimed at expanding product portfolios and geographic reach.
For instance, in February 2023, Teleflex received U.S. FDA 510(k) clearance for its Triumph Catheter, featuring an innovative design that enables precise wire advancement and enhanced visualization. In December 2022, Boston Scientific announced a strategic investment to acquire a majority stake in Acotec Scientific Holdings Limited, a Chinese medical technology company known for its thrombus aspiration catheters and RF ablation technologies, with the aim of strengthening its regional presence. Additionally, in 2022, B. Braun Melsungen launched Dican Flex, a single-use safety catheter designed for peripheral vascular access in extracorporeal blood purification therapy.
Related Report:
HPV Testing and PAP Test Market – https://www.pharmiweb.com/press-release/2025-12-18/hpv-testing-and-pap-test-market-share-size-growth-forecast-till-2030
Cellular Health Screening Market – https://www.pharmiweb.com/press-release/2025-12-18/cellular-health-screening-market-2030-analysis-size-share-growth-trends-and-forecast
Hematology Market – https://www.pharmiweb.com/press-release/2025-12-18/hematology-market-outlook-2030-industry-trends-and-competitive-analysis
Long-Term Care Software Market – https://www.pharmiweb.com/press-release/2025-12-18/long-term-care-software-market-demand-for-evidence-based-medicine-and-research-updates
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79